Catalog No.
Product Name
Application
Product Information
Citations
-
Antibacterial Agent
Antibacterial agent 99 (compound 7b) is a potent antibacterial compound that targets bacterial cell wall synthesis. It exhibits significant antibacterial and antifungal activity, making it suitable for various microbiological research applications. Additionally, antibacterial agent 99 demonstrates no hemolytic activity, indicating a favorable safety profile for potential therapeutic use. -
Bacterial Inhibitor
Acrisorcin is a topical anti-infective compound that functions primarily as a bacterial inhibitor. It exhibits potent fungicidal properties, making it valuable for research into antifungal therapies and the understanding of bacterial resistance mechanisms. Its efficacy in mitigating fungal infections supports its application in various microbiological studies and therapeutic evaluations. -
Antibacterial Agent
Antibacterial Agent 45 is an effective antibacterial compound that enhances the efficacy of Ceftazidime by significantly lowering its minimum inhibitory concentration (MIC) value. This agent demonstrates potent antibacterial activity, making it a valuable tool for researchers studying bacterial resistance and developing novel antimicrobial therapies. Its application in combinatorial therapies holds promise for advancing understanding of bacterial pathogenesis and treatment strategies. -
Antibacterial Agent
Prenylterphenyllin is an antibacterial agent derived from the marine fungus Aspergillus candidus IF10. It exhibits significant cytotoxic activity against KB3-1 cells, with an IC50 value of 8.5 mg/mL. Additionally, Prenylterphenyllin demonstrates antibacterial properties against Xanthomonas oryzae and Erwinia amylovora, both exhibiting minimum inhibitory concentrations (MICs) of 20 μg/mL. This compound is useful for research in antimicrobial drug development and the study of marine-derived natural products. -
Antibacterial agent
Antibacterial Agent 245 (Dc-2) is an effective antibacterial compound targeting plant pathogenic fungi and bacteria. It demonstrates a potent activity with an EC50 value of 1.29 μg/mL against Botrytis cinerea. This reagent is suitable for research applications in plant pathology and the development of biocontrol agents. -
Anti-Bacterial Agent
Galacardin A is an anti-bacterial agent that primarily exhibits activity against Gram-positive bacteria. Its mechanism of action involves disrupting bacterial cell wall synthesis, resulting in inhibition of bacterial growth. Galacardin A is suitable for research applications focused on developing new antibacterial therapies and studying microbial resistance. -
Anti-Bacterial Agent
Polymyxin S1 is an anti-bacterial agent derived from Bacillus polymyxa RS-6, known for its potent activity against Gram-negative bacteria. This compound disrupts bacterial cell membrane integrity, leading to cell lysis and death. Polymyxin S1 is primarily utilized in research focusing on antibiotic action mechanisms and the development of new antimicrobial strategies. It offers valuable insights for studies targeting drug resistance and the efficacy of antibacterial compounds. -
Anti-Bacterial Agent
Pacidamycin 5 is an anti-bacterial agent that exhibits inhibitory activity against Pseudomonas aeruginosa. Additionally, it demonstrates effectiveness against various strains of bacteria, including Staphylococcus aureus and Escherichia coli. This compound is valuable for research applications focused on the development of novel antibacterial therapies. -
Anti-Bacterial Agent
Cephamycin A is an antibiotic that primarily targets bacterial cell wall synthesis. It exhibits moderate antibacterial activity against a range of Gram-positive and Gram-negative bacteria. This compound is useful in research applications focused on developing novel antibacterial agents and studying bacterial resistance mechanisms. -
Anti-Bacterial Agent
Fluoropolyoxin M is an anti-bacterial agent that exhibits inhibitory activity against Escherichia coli and Streptococcus faecalis. This compound is primarily utilized in research focused on bacterial infections and antibiotic resistance mechanisms. Its effectiveness against these pathogens makes it a valuable tool for studies in microbiology and pharmacology. -
Bacterial Inhibitor
CID21480113 is an inhibitor targeting bacterial pathways, specifically effective against dapsone-resistant strains of leprosy. This compound demonstrates significant antibacterial activity, making it a valuable tool for research in microbial resistance and infectious disease studies. Its ability to combat resistant bacteria positions CID21480113 as a relevant reagent for investigations into alternative therapies for leprosy. -
Anti-Bacterial Agent
Cyclacidin is an anti-bacterial agent targeting Gram-positive bacteria, including Bacillus subtilis and Gambusia occidentalis. It exhibits significant antimicrobial activity and demonstrates an inhibitory effect on sarcoma 180 cells. This compound is valuable for research applications focused on bacterial infections and cancer therapeutic strategies. -
Streptomycin Biosynthesis Inducer
A-Factor is a potent inducer of streptomycin biosynthesis in the inactive mutant strain of Streptomyces griseus. Additionally, A-Factor promotes spore formation during the conidial development of Magnaporthe oryzae. This reagent is valuable for researchers studying antibiotic production and fungal development processes. -
Anti-Bacterial Agent
1-Hydroxycrisamicin A is an effective anti-bacterial agent primarily targeting Gram-positive bacteria. It exhibits potent activity with a minimum inhibitory concentration (MIC) ranging from 0.78 to 3.12 μg/mL. This compound holds significant potential for research applications in the study of bacterial infections and the development of new antimicrobial therapies. -
Anti-Bacterial Agent
Pacidamycin 2 is an antibacterial agent that primarily targets and inhibits Pseudomonas aeruginosa. It also demonstrates activity against various strains of bacteria, including Suppurative Staphylococcus and Escherichia coli. This compound is useful in antibacterial research and investigation of microbial resistance. -
Antibacterial Peptide
CP7-FP13-2 is an antibacterial peptide that targets virulence factors in bacteria. It effectively inhibits the formation of biofilms in Staphylococcus aureus, demonstrating potent antibacterial activity in in vivo mouse models. This compound is valuable for research applications focusing on microbial resistance and the development of alternative therapeutic strategies against bacterial infections. -
Antibacterial Agent
γ-Rubromycin is a natural compound derived from Streptomyces, primarily acting as an antibacterial agent. It exhibits significant antibacterial activity, making it a valuable tool for exploring microbial resistance mechanisms and developing new therapeutic strategies against bacterial infections. This reagent is suitable for research applications focused on antimicrobial efficacy and the biochemical pathways associated with bacterial pathogens. -
Antibacterial Agent
Beauvericin A is a cyclodepsipeptide with potent antibacterial activity, primarily targeting Mycobacterium tuberculosis and Plasmodium falciparum. It exhibits a minimum inhibitory concentration (MIC) of 25 μg/mL against M. tuberculosis and an IC50 of 12 μg/mL against P. falciparum, demonstrating its potential as a valuable agent in infectious disease research. Additionally, Beauvericin A shows toxicity to brine shrimp, indicating its bioactive properties that can be explored in various biological assays. -
Antibacterial Agent
Norfloxacin succinil is a quinolone antibacterial agent that targets bacterial DNA gyrase and topoisomerase IV, leading to the inhibition of DNA replication and repair. This compound exhibits effective antimicrobial activity against a range of Gram-negative and Gram-positive bacteria. It is primarily utilized in research related to infectious diseases, particularly in the study of urinary tract infections. -
Antibacterial Agent
Antibacterial Agent 281 specifically targets the growth of Streptococcus pyogenes (GAS) through bacteriostatic inhibition. This compound binds to the ligand binding pocket of SPs0871, effectively competing with the native ligand. Antibacterial Agent 281 demonstrates concentration-dependent inhibition of S. pyogenes growth, making it a valuable tool for research into antibacterial mechanisms and therapeutic development. -
Anti-Bacterial Agent
Kibdelin B is an anti-bacterial agent that targets Gram-positive bacteria, exhibiting significant activity against Staphylococcus aureus, including methicillin-resistant strains (MRSA). Its mechanism of action parallels that of Vancomycin, making it a valuable compound for research applications in developing new therapeutic strategies against resistant bacterial infections. -
Anti-Bacterial Agent
Amidinomycin is an antibacterial agent that primarily targets Gram-positive bacteria. It exhibits moderate antibacterial activity, making it useful for studying bacterial resistance mechanisms and evaluating potential therapeutic strategies. Its efficacy in inhibiting Gram-positive strains positions it as a valuable reagent for microbiological research and drug development. -
Antioxidant/Antibacterial Agent
Eriodictyol 7, 3'-dimethyl ether is a flavonoid compound known for its antioxidant and antibacterial properties. Extracted from Berberis riparia, this compound demonstrates significant potential in mitigating oxidative stress and inhibiting bacterial growth. It is valuable for research applications focused on natural antioxidants and the development of antibacterial agents. -
Anti-Bacterial Agent
Saframycin Mx2 is an anti-bacterial agent that exhibits potent activity against both Gram-positive and Gram-negative bacteria. Its mechanism involves the inhibition of bacterial growth, making it valuable for research applications focused on antibiotic development and studies in microbial resistance. Saframycin Mx2 is suitable for use in various biological assays and exploration of antibacterial efficacy. -
Anti-Bacterial Agent
Peptaibolin is an anti-bacterial agent primarily targeting Gram-positive bacteria and yeast. It exhibits inhibitory activity against Staphylococcus subtilis ATCC 6633 and Candida albicans, with minimum inhibitory concentrations (MICs) of 100 μg/mL for both organisms. Due to its selective activity, Peptaibolin is useful for research applications aimed at understanding bacterial and fungal resistance mechanisms. -
Antibiofilm Agent
Antibiofilm agent-14 is a potent antibiofilm agent targeting fungal biofilm formation. It exhibits notable antifungal activity against Candida albicans strain SC5314, demonstrating a minimum inhibitory concentration (MIC) of 50 μM. This compound is valuable for research applications focusing on biofilm-related infections and strategies to combat fungal resistance. -
Anti-Bacterial Agent
Chimeramycin A is an antibiotic compound that exhibits potent anti-Gram-positive bacterial and mycoplasma activity. It disrupts bacterial protein synthesis, making it an effective agent in combating infections caused by resistant strains. This compound is valuable for research applications focused on antibiotic resistance and the development of new antibacterial therapies. -
Anti-Bacterial Agent
Griseochelin is an anti-bacterial agent known for its robust activity against Gram-negative bacteria. Additionally, it demonstrates inhibitory effects on Coccidioides species, making it a valuable compound for research into fungal infections. Its unique properties make it suitable for investigations in both antimicrobial and antifungal applications. -
Bacterial Inhibitor
o-Cymen-5-ol acts as a broad-spectrum antimicrobial agent targeting various bacterial and fungal pathogens. It demonstrates effective minimum inhibitory concentrations (MICs) against organisms such as Streptococcus mutans and Candida albicans. Notably, o-Cymen-5-ol exhibits synergistic effects when combined with zinc, enhancing its antimicrobial activity against oral pathogens by inhibiting glycolysis. Studies indicate a more pronounced antibacterial effect in formulations such as toothpaste compared to placebo. This compound is valuable for research applications in microbiology and dental health. -
Anti-Bacterial Agent
Cephaibol D is an anti-bacterial agent derived from the Acremonium tubae strain DSM 12774. This compound exhibits weak antibacterial activity, making it a candidate for exploring mechanisms of antimicrobial resistance and the development of novel therapeutic agents. Its potential applications include studying bacterial metabolism and assessing the efficacy of various antimicrobial strategies. -
Antibacterial Agent
GDI-5755 is an antibacterial agent that targets and inhibits ClpP1P2, effectively reducing the growth of Mycobacterium tuberculosis and Mycobacterium bovis BCG. This compound is relevant for research applications focused on tuberculosis (TB) and provides a valuable tool for the study of mycobacterial infections. Its mechanism of action makes GDI-5755 a promising candidate for further investigation in the development of therapeutic strategies against TB. -
Anti-Bacterial Agent
Phencomycin is an anti-bacterial agent with a modest inhibitory effect on Gram-positive bacteria. Additionally, it targets the enzyme renin, affecting its activity with an IC50 of 440 μg/mL. This compound is useful in studies focused on bacterial resistance and enzyme modulation in physiological processes. -
Antibacterial Agent
Arizonin C1 is a microbial metabolite that functions as an antibacterial agent targeting Gram-positive bacteria. It exhibits significant antimicrobial activity, making it a valuable compound for research in the study of bacterial infections and the development of new antimicrobial therapies. Arizonin C1's unique properties contribute to its potential applications in antibiotic resistance studies and the discovery of novel antibacterial agents. -
Antibacterial Drug
LY 215891 is an antibacterial agent that demonstrates potent activity against both Gram-positive and Gram-negative bacteria. It achieves minimum inhibitory concentrations (MICs) of 0.015 μg/mL against Klebsiella pneumoniae X26 and 0.06 μg/mL against Escherichia coli EC14. This compound is valuable for research applications focusing on the development of novel antibacterial therapeutics and the study of bacterial resistance mechanisms. -
Anti-Bacterial Agent
Neoviridogrisein I is an anti-bacterial agent that selectively inhibits the growth of Gram-positive bacteria and mycoplasma. Its biological activity makes it a valuable tool in microbiological research and the study of bacterial resistance mechanisms. This compound can be employed in various experimental settings to further investigate bacterial pathogenesis and develop potential therapeutic strategies. -
Antibiotic
Sannamycin J is an aminoglycoside antibiotic that exhibits antimicrobial properties. Isolated from Streptomyces sannanensis sp. KC-7038, it demonstrates weak antibacterial activity against both Gram-positive and Gram-negative bacteria. This compound serves as a valuable tool for research in antibiotic mechanisms and microbial resistance studies. -
Anti-Bacterial Agent
Monorden C is an anti-bacterial agent that effectively arrests the cell cycle of Jurkat cells in the G1 and G2/M phases. This compound demonstrates significant anti-Aspergillus niger activity, making it a valuable tool in research focused on fungal infections and cell cycle regulation. Its mechanisms of action provide insights into cellular responses to bacterial and fungal challenges, facilitating studies in both microbiology and cell biology. -
Anti-Bacterial Agent
Azicemicin B is an antibacterial agent that exhibits weak antimicrobial activity. Its low toxicity profile has been demonstrated in mouse models, making it a candidate for further evaluation in microbial research and potential therapeutic applications. This compound may be useful in studies exploring the mechanisms of bacterial resistance and the development of novel antibacterial strategies. -
Anti-Bacterial Agent
Emerimicin IV is an anti-bacterial agent that exhibits potent activity against Gram-positive bacteria. It interferes with bacterial protein synthesis, making it a valuable compound for research focused on developing new antimicrobial therapies. This reagent is particularly useful in studies investigating bacterial resistance and the mechanisms of action of antibiotics. -
Anti-Bacterial Agent
Lactonamycin is an anti-bacterial agent known for its potent activity against Gram-positive bacteria, specifically Staphylococcus, Streptococcus, Enterococcus, MRSA, and VRE, with minimum inhibitory concentrations (MIC) ranging from 0.39 to 0.78 μg/mL. Additionally, Lactonamycin demonstrates cytotoxic effects on various tumor cell lines, including L-1210, P388, S180, FS-3, Ehrlich, and B16-BL5, exhibiting IC50 values between 0.06 and 3.3 μg/mL. This compound is valuable for research focused on bacterial resistance and cancer therapeutics. -
Anti-Bacterial Agent
Nocathiacin II is a potent anti-bacterial agent primarily effective against Gram-positive bacteria. It demonstrates significant resistance to strains such as methicillin-resistant Staphylococcus aureus (MRSA), penicillin-resistant Streptococcus pneumoniae (PRSP), and multidrug-resistant Enterococcus faecalis (MREF). This compound is ideal for research applications focused on combating antibiotic resistance and developing effective antibacterial therapies. -
Bacterial Inhibitor
Strinoline is a bacterial inhibitor that targets and disrupts bacterial cell function. This compound exhibits significant antibacterial activity, making it a valuable tool for research in the field of microbiology. Strinoline can be utilized to study bacterial resistance mechanisms and the efficacy of antibiotic therapies. -
Antibiotic
Trinactin is a macrotetrolide antibiotic that displays potent antibacterial activity through the disruption of bacterial cell membranes. Additionally, it functions as a cation carrier, facilitating ion transport across cellular membranes. This compound is significant for research applications focused on antibiotic development, cellular ion exchange mechanisms, and studying the effects of ionophore activity in various biological systems. -
Anti-Bacterial Agent
Enaminomycin C is an anti-bacterial agent with a demonstrated ability to inhibit the growth of Gram-positive bacteria. Its activity profile shows weak effectiveness against Gram-negative bacteria, making it a candidate for further investigation in antibacterial research. Studies involving Enaminomycin C may contribute to the development of new therapeutic strategies against bacterial infections. -
Antibacterial Agent
Tacapenem, the active metabolite of CS-834, functions as a potent antibacterial agent. It demonstrates a broad spectrum of antibacterial activity against both gram-positive and gram-negative aerobes and anaerobes. Notably, Tacapenem exhibits strong bactericidal effects against Staphylococcus aureus and Escherichia coli, making it a valuable tool for research in bacterial infections and antibiotic resistance studies. -
Antibacterial Agent
Antibacterial agent 170 (compound 6b) is a potent antibacterial compound that targets the inhibition of biofilm formation in Pseudomonas aeruginosa PAO1. It demonstrates significant activity as a quorum sensing inhibitor through the las system, effectively disrupting bacterial communication and biofilm development. This agent is valuable for studies focused on microbial resistance and the mechanisms underlying bacterial pathogenicity. -
Antibacterial Agent
Colupulone is a β-acid resin derived from hops (Humulus lupulus) known for its antibacterial properties. It demonstrates significant activity against a range of bacteria as well as anti-larval effects on Culex mosquitoes. This compound is useful for investigations into infectious diseases and the development of novel antibacterial agents. -
Anti-Bacterial Agent
Kerriamycin C is an anti-bacterial agent targeting Gram-positive bacteria. It exhibits significant antibacterial activity, making it valuable for research in infectious disease and antimicrobial resistance. Additionally, Kerriamycin C has shown the ability to inhibit ascites cancer in experimental models, suggesting potential applications in cancer research. -
Antibacterial Agent
Anti-MRSA Agent 37 is an antibacterial agent specifically targeting methicillin-resistant Staphylococcus aureus (MRSA), with a minimum inhibitory concentration (MIC) of 0.25-0.5 μg/mL. This compound effectively inhibits biofilm formation, disrupts cell wall integrity, compromises cell membrane stability, and induces oxidative stress in bacterial cells. It holds potential for research applications related to MRSA-associated diseases, particularly skin infections. -
Antibiotic
2'''-Hydroxychlorothricin is an antibiotic derived from the chlorothricin group, primarily targeting bacterial infections. Isolated from Streptomyces sp. K818, it exhibits anti-tumor properties and has been shown to extend the survival of ICR mice inoculated with Ehrlich cancer cells. This compound serves as a valuable tool in cancer research and microbiological studies focusing on antibiotic efficacy and tumor treatment.
